Gavi to give $500 mn to India for immunisation programme
Advertisement
NEW DELHI: A global agency has committed to offer $500 million to the Indian government over the next five years for supporting immunisation programme in the country.
Geneva-based Gavi, a global vaccine alliance funded by Bill and Melinda Gates Foundation, among other donor organisations, has pledge this amount.
Additional Secretary, Health, C K Mishra said Gavi Board that monitors vaccine implementation programme will provide $500 million to support the government for next five years.
"Gavi Board last week approved our proposal which was being doubted all over. According to the proposal, they will give $500 million over the next five years. The major vaccines we are looking forward to support with this amount are rotavirus, measles-rubella, PCV vaccine and also as when we decide to introduce HPV,"he said.
The total immunisation budget of the government is Rs 600 crore, which Mishra said will go upto Rs 1,800 crores by next year.
Government has also taken over the task of implementing Pentavalent vaccine in its immunization programme at a cost of Rs 750 crore annually from next year which was earlier being taken care of by the Gavi Board.
"The Pentavalent vaccine has already been rolled out in all states of the country. It was supported by Gavi till the end of this year. We have have decided to take over the implement of Pentavalent with our domestic budget by next year which will be Rs 750 crore," Mishra said.
About 8.8 to 9 crore doses of pentavalent will be required annualy for which procurement process has been started, he said.
"8.8 crore doses will be required. Orders and tenders have been given," he said.
Through the transition, government is looking more for health system-strengthening support than commodity-driven support, he said.
Geneva-based Gavi, a global vaccine alliance funded by Bill and Melinda Gates Foundation, among other donor organisations, has pledge this amount.
Additional Secretary, Health, C K Mishra said Gavi Board that monitors vaccine implementation programme will provide $500 million to support the government for next five years.
"Gavi Board last week approved our proposal which was being doubted all over. According to the proposal, they will give $500 million over the next five years. The major vaccines we are looking forward to support with this amount are rotavirus, measles-rubella, PCV vaccine and also as when we decide to introduce HPV,"he said.
The total immunisation budget of the government is Rs 600 crore, which Mishra said will go upto Rs 1,800 crores by next year.
Government has also taken over the task of implementing Pentavalent vaccine in its immunization programme at a cost of Rs 750 crore annually from next year which was earlier being taken care of by the Gavi Board.
"The Pentavalent vaccine has already been rolled out in all states of the country. It was supported by Gavi till the end of this year. We have have decided to take over the implement of Pentavalent with our domestic budget by next year which will be Rs 750 crore," Mishra said.
About 8.8 to 9 crore doses of pentavalent will be required annualy for which procurement process has been started, he said.
"8.8 crore doses will be required. Orders and tenders have been given," he said.
Through the transition, government is looking more for health system-strengthening support than commodity-driven support, he said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.